Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Intravenous Solutions

Enquire | Email | Print

Published Date: Jul, 2013
Format: PDF
No of Pages: 275
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

This market insight report on IV (Intravenous) Solutions is analyzed by Type and Nutrients for each of the geographic regions-North America, Europe, Asia-Pacific and Rest of World. The global IV Solutions market segments includes by Type- Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients-Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Estimations and predictions for the total global IV solutions market are given by geographic regions. Business profiles of 16 major companies are discussed in the report. The report covers more than 50 companies that are engaged in IV Solutions and related products. Major Contract Research Organizations serving IV Solution market are also covered in the Corporate Directory section of this report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is also included in the report. A total of 110 exclusive graphically represented exhibits complement the text.

Report Highlights

This report may help strategists, investors, laboratories, contract research organizations, biotechnology & Healthcare companies, academic professionals, drug approval authorities, and other organizations to –
• Identify Market Opportunities
• Review and Analyze Global and Regional Markets
• Gauge Market Potential for your Products
• Identify Competition
• Use Market Research for exploring new areas
• Acquire Meaningful Guidelines for Strategic Planning
• Gear up for Market Entry
• Get Actionable Information

Analytics and data presented in each report pertain to several parameters such as –
• Global and Regional Market Sizes, Market Shares, Market Trends
• Product (Global and Regional) Market Sizes, Market Shares, Market Trends
• Technology Trends
• Corporate Intelligence
• Key Companies By Sales, Brands, Products
• Other Strategic Business Affecting Data

Key Report Findings

Global Intravenous Solutions market is projected to grow at 13.79% compounded annually from 2005 through 2015. Several companies that supply intravenous solutions have come up with innovations in their product lines. An industry leader in this field, Baxter International, rapidly expanded its product line of pre-mixed frozen intravenous solutions. Abbot Labs designed a system in which bottles of powdered drugs could be directly introduced into the bag of intravenous fluid as required. The lids of these bottles are screwed open inside the sterile bags and the drugs are subsequently introduced into the solution and mixed by shaking.

Intravenous feeding is the short-term administration of supplementary nutrients through a solution that is introduced into the vein. Peripheral intravenous feeding refers to infusion of the fluid in a small vein on the surface of an arm, leg or the scalp. On the other hand, central venous feeding refers to infusion into a large vein which is embedded deep within a body. Only limited quantities of nutrients can be administered through peripheral intravenous feeding as there is the danger of incurring phlebitis and/or clots (thrombi) if concentrated solutions are used. However, in central venous feeding it is possible to infuse concentration nutrient solutions as the rapid blood flow in the central veins can promptly dilute the solution thereby minimizing the possibility of causing irritation to the vein.

When IV solutions are produced locally in medically emerging countries, the resulting return on initial investments can be quite small. It is estimated that profitability would stand at only 50% of the total production capacity. The production costs that are incurred in developing IV solutions are 45% to 65% lower than the existing market price for primary product lines. These estimates are based on U.S. cost figures. When the U.S. system of calculation is used, both direct and indirect labor costs are the largest cost factors. However, in developing nations, the labor cost is relatively low and the cost of IV solutions is much higher. Therefore, the actual production cost can be estimated to be 60% to 90% lower than the market price of the product. There is a very high demand for IV solutions. Therefore, even if a situation arises in which production is more than the local demand, there are still excellent prospects of making national sales as well as sales through exports. The raw materials that are required to produce IV solutions are easy to procure as they are readily available in local markets.

Companies Discussed

Ajinomoto Co., Inc. (Japan)
B. Braun Melsungen AG (Germany)
Baxter International (USA)
Baxter (India) Pvt. Ltd. (India)
Claris Lifesciences Ltd. (India)
Fresenius Kabi AG (Germany)
Hospira, Inc. (USA)
Kyowa Hakko Bio Co., Ltd. (Japan)
Laboratorios Grifols SA (Spain)
Liqvor Pharmaceuticals (Armenia)
Marck Biosciences Ltd. (India)
Otsuka Pharmaceutical Co., Ltd. (Japan)
Pfizer, Inc. (USA)
Sichuan Kelun Pharmaceutical Co., Ltd. (China)
Sino-Swed Pharmaceutical Corp., Ltd. (China)

1. SCOPE AND METHODOLOGY

2. REPORT SYNOPSIS

2.1 Introduction
History
Definitions
Intravenous
Intravenous Infusion
Parenteral
Enteral
Home Parenteral Nutrition (HPN)
Partial Parenteral Nutrition (PPN)
Total Parenteral Nutrition (TPN)
Benefits
Hazards of Intravenous Feeding
2.2 Segmentation of Intravenous Solutions
Exhibit 1. Segmentation of Intravenous Solutions Market by Type and Nutrients
Types
Partial Parenteral Nutrition
Total Parenteral Nutrition
Nutrients
Carbohydrates
Salt & Electrolytes
Minerals & Vitamins
Amino-Acids
2.2 Intravenous Solutions - Global Market Analysis
Exhibit 2. Intravenous Solutions - Global Historic Market (2000-2010) in US$ Billion (Graphical Representation Included)
Exhibit 3. Intravenous Solutions - Global Market Estimations & Predictions (2011 - 2020) in US$ Billion (Graphical Representation Included)
Exhibit 4. List of Major Global Companies in Intravenous Solutions Market

3. MARKET DYNAMICS
3.1 Market Overview
3.2 Global Intravenous Solutions Market
Exhibit 5. Intravenous Solutions - Global Historic Market (2000-2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion(Graphical Representation Included)
Exhibit 6. Intravenous Solutions - Global Market Shares (2005 & 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 7. Intravenous Solutions - Global Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
Exhibit 8. Intravenous Solutions - Global Market Shares (2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.3 North America Intravenous Solutions Market
Exhibit 9. Intravenous Solutions - North American Market Estimations & Predictions (2005 - 2020) by Country for United States and Canada in US$ Billion (Graphical Representation Included)
Exhibit 10. Intravenous Solutions – North American Market Shares (2010, 2015 & 2020) by Country for United States and Canada (Graphical Representation Included)
3.3 (I) US Intravenous Solutions Market
3.3 (II) Canadian Intravenous Solutions Market
Exhibit 11. List of Major North American Intravenous Solutions Companies
3.4 European Intravenous Solutions Market
Exhibit 12. Intravenous Solutions - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 13. Intravenous Solutions - European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, France, Switzerland, Russia and Rest of Europe
3.4 (I) German Intravenous Solutions Market
3.4 (II) UK Intravenous Solutions Market
3.4 (III) French Intravenous Solutions Market
3.4 (IV) Swiss Intravenous Solutions Market
3.4 (V) Russian Intravenous Solutions Market
Exhibit 14. List of Major European Intravenous Solutions Companies
3.5 Asia-Pacific Intravenous Solutions Market
Exhibit 15. Intravenous Solutions - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 16. Intravenous Solutions - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.5 (I) Japanese Intravenous Solutions Market
3.5 (II) Chinese Intravenous Solutions Market
3.5 (III) Indian Intravenous Solutions Market
3.5 (IV) Australian Intravenous Solutions Market
3.5 (V) South Korean Intravenous Solutions Market
Exhibit 17. List of Major Asia-Pacific Intravenous Solutions Companies
3.6 Rest of World Intravenous Solutions Market
Exhibit 18. Intravenous Solutions - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Brazil, Israel, South African and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 19. Intravenous Solutions - Rest of World Market Shares (2010, 2015 & 2020) by Country for Brazil, Israel, South African and Rest of World
3.6 (I) Brazilian Intravenous Solutions Market
3.6 (II) Israeli Intravenous Solutions Market
3.6 (III) South African Intravenous Solutions Market
Exhibit 20. List of Major Rest of World Intravenous Solutions Companies
3.7 Company Profiles - Major Global Players in Intravenous Solutions Market
Ajinomoto Co., Inc.
B.Braun Melsungen AG
Baxter International
Fresenius Kabi AG
Hospira, Inc.
Laboratorios Grifols SA
Liqvor Pharmaceuticals
More…
3.8 Competition Analysis
Exhibit 21. Clinical Nutrition – Global Market Shares (2009) by Major Companies (Graphical Representation Included)
Exhibit 22. Intravenous Solution– Global Market Shares (2009) by Major Companies (Graphical Representation Included)
Exhibit 23. Major Companies in Intravenous Solutions Industry – Annual Sales for 2006 through 2010 in US$ Million
Exhibit 24. Major Companies in Intravenous Solutions Industry – Production Volume and Capacity in Unit/Tonnes/Liters
Exhibit 25. Intravenous Solutions – Competitor Price Comparison
3.9 Major Activities in Intravenous Solutions Market
BPC’s BIVIGAM™, a New Intravenous Immune Globulin Gains US FDA Approval
Hospira Recalls Electrolyte Solution
Otsuka, Mitsui and Claris Establish an IV Solutions Joint Venture Business in India
Kyowa Hakko Kirin Introduces the new NESP® INJECTION PLASTIC SYRINGE with Unified Injection Volume
Taiho Pharmaceutical Releases 5-HT3 Receptor Antagonist Aloxi® I.V. Infusion bag 0.75mg
Merck to Give Back Vernakalant’s Worldwide Marketing and Development Rights to Cardiome
Baxter Healthcare to Withdraw Automix Automated Nutrition Compounder Systems
Rienso® (ferumoxytol) Attains Marketing Authorization by EC for Iron Deficiency Anaemia Treatment in Adult Chronic Kidney Disease Patients
More….
3.10 Analysis by Type
Exhibit 26. Intravenous Solutions by Type - Global Historic Market (2000-2010) for PPN and TPN in US$ Billion (Graphical Representation Included)
Exhibit 27. Intravenous Solutions by Type - Global Market Shares (2005 & 2010) for PPN and TPN (Graphical Representation Included)
Exhibit 28. Intravenous Solutions by Type - Global Market Estimations & Predictions (2011 - 2020) for PPN and TPN in US$ Billion (Graphical Representation Included)
Exhibit 29. Intravenous Solutions by Type - Global Market Shares (2015 & 2020) for PPN and TPN (Graphical Representation Included).
3.10.1 Partial Parenteral Nutrition
3.10.1.1 Global Market for Intravenous Solutions as Partial Parenteral Nutrition
Exhibit 30. Intravenous Solutions as Partial Parenteral Nutrition - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 31. Intravenous Solutions as Partial Parenteral Nutrition - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.10.1.2 North America Market for Intravenous Solutions as Partial Parenteral Nutrition
Exhibit 32. Intravenous Solutions as Partial Parenteral Nutrition - North American Market Estimations & Predictions (2005 - 2020) by Country for US and Canada in US$ Billion (Graphical Representation Included)
Exhibit 33. Intravenous Solutions as Partial Parenteral Nutrition - North American Market Shares (2010, 2015 & 2020) by Country US and Canada (Graphical Representation Included)
3.10.1.2 (I) US Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.2 (II) Canadian Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.3 European Market for Intravenous Solutions as Partial Parenteral Nutrition
Exhibit 34. Intravenous Solutions as Partial Parenteral Nutrition - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 35. Intravenous Solutions as Partial Parenteral Nutrition - European Market Shares (2010, 2015 & 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.10.1.3 (I) German Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.3 (II) French Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.3 (III) UK Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.3 (IV) Swiss Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.3 (V) Russian Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.4 Asia-Pacific Market for Intravenous Solutions as Partial Parenteral Nutrition
Exhibit 36. Intravenous Solutions as Partial Parenteral Nutrition - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 37. Intravenous Solutions as Partial Parenteral Nutrition - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
3.10.1.4 (I) Japanese Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.4 (II) Chinese Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.4 (III) Indian Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.4 (IV) Australian Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.4 (V) South Korean Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.5 Rest of World Market for Intravenous Solutions as Partial Parenteral Nutrition
Exhibit 38. Intravenous Solutions as Partial Parenteral Nutrition - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Israel, Brazil, South Africa and Other Countries in US$ Million (Graphical Representation Included).
Exhibit 39. Intravenous Solutions as Partial Parenteral Nutrition - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, Brazil, South Africa and Other Countries
3.10.1.5 (I) Israeli Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.5 (II) Brazilian Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.1.5 (III) South African Market for Intravenous Solutions as Partial Parenteral Nutrition
3.10.2 Total Parenteral Nutrition
3.10.2.1 Global Market for Intravenous Solutions as Total Parenteral Nutrition
Exhibit 40. Intravenous Solutions as Total Parenteral Nutrition - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 41. Intravenous Solutions as Total Parenteral Nutrition - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.10.2.2 North American Market for Intravenous Solutions as Total Parenteral Nutrition
Exhibit 42. Intravenous Solutions as Total Parenteral Nutrition - North American Market Estimations & Predictions (2005 - 2020) by Country for US and Canada in US$ Billion (Graphical Representation Included)
Exhibit 43. Intravenous Solutions as Total Parenteral Nutrition - North American Market Shares (2010, 2015 & 2020) by Country for US and Canada (Graphical Representation Included)
3.10.2.2 (I) US Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.2 (II) Canadian Market for Intravenous Solutions as Total Parenteral Nutrition
Exhibit 44. List of Major North American Intravenous Solutions as Total Parenteral Nutrition Companies
3.10.2.3 European Market for Intravenous Solutions as Total Parenteral Nutrition
Exhibit 45. Intravenous Solutions as Total Parenteral Nutrition - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 46. Intravenous Solutions as Total Parenteral Nutrition - European Market Shares (2010, 2015 & 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.10.2.3 (I) German Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.3 (II) French Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.3 (III) UK Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.3 (IV) Swiss Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.3 (V) Russian Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.4 Asia-Pacific Market for Intravenous Solutions as Total Parenteral Nutrition
Exhibit 47. Intravenous Solutions as Total Parenteral Nutrition - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in US$ Million
Exhibit 48. Intravenous Solutions as Total Parenteral Nutrition - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
3.10.2.4 (I) Japanese Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.4 (II) Chinese Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.4 (III) Indian Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.4 (IV) Australian Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.4 (V) South Korean Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.5 Rest of World Market for Intravenous Solutions as Total Parenteral Nutrition
Exhibit 49. Intravenous Solutions as Total Parenteral Nutrition - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Israel, Brazil, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 50. Intravenous Solutions as Total Parenteral Nutrition - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, Brazil, South Africa and Other Countries
3.10.2.5 (I) Israeli Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.5 (II) Brazilian Market for Intravenous Solutions as Total Parenteral Nutrition
3.10.2.5 (III) South African Market for Intravenous Solutions as Total Parenteral Nutrition
3.11 Analysis by Nutrients
Exhibit 51. Intravenous Solutions by Nutrients - Global Historic Market (2000-2010) for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids and Other in US$ Billion (Graphical Representation Included)
Exhibit 52. Intravenous Solutions by Nutrients - Global Market Shares (2005 & 2010) for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids and Other (Graphical Representation Included)
Exhibit 53. Intravenous Solutions by Nutrients - Global Market Estimations & Predictions (2011 - 2020) for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Billion (Graphical Representation Included)
Exhibit 54. Intravenous Solutions by Nutrients - Global Market Shares (2015 & 2020) for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
3.11.1 Carbohydrates
3.11.1.1 Global Carbohydrate Intravenous Solutions Market
Exhibit 55. Carbohydrate Intravenous Solutions - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 56. Carbohydrate Intravenous Solutions - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World
3.11.1.2 North American Carbohydrate Intravenous Solutions Market
Exhibit 57. Carbohydrate Intravenous Solutions - North American Market Estimations & Predictions (2005 - 2020) by Country for US and Canada in US$ Billion (Graphical Representation Included)
Exhibit 58. Carbohydrate Intravenous Solutions - North American Market Shares (2010, 2015 & 2020) by Country for US and Canada (Graphical Representation Included)
3.11.1.2 (I) US Carbohydrate Intravenous Solutions Market
3.11.1.2 (II) Canadian Carbohydrate Intravenous Solutions Market
3.11.1.3 European Carbohydrate Intravenous Solutions Market
Exhibit 59. Carbohydrate Intravenous Solutions - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 60. Carbohydrate Intravenous Solutions - European Market Shares (2010, 2015 & 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.11.1.3 (I) German Carbohydrate Intravenous Solutions Market
3.11.1.3 (II) French Carbohydrate Intravenous Solutions Market
3.11.1.3 (III) UK Carbohydrate Intravenous Solutions Market
3.11.1.3 (IV) Swiss Carbohydrate Intravenous Solutions Market
3.11.1.3 (V) Russian Carbohydrate Intravenous Solutions Market
3.11.1.4 Asia-Pacific Carbohydrate Intravenous Solutions Market
Exhibit 61. Carbohydrate Intravenous Solutions - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 62. Carbohydrate Intravenous Solutions - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
3.11.1.4 (I) Japanese Carbohydrate Intravenous Solutions Market
3.11.1.4 (II) Chinese Carbohydrate Intravenous Solutions Market
3.11.1.4 (III) Indian Carbohydrate Intravenous Solutions Market
3.11.1.4 (IV) Australian Carbohydrate Intravenous Solutions Market
3.11.1.4 (V) South Korean Carbohydrate Intravenous Solutions Market
3.11.1.5 Rest of World Carbohydrate Intravenous Solutions Market
Exhibit 63. Carbohydrate Intravenous Solutions - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Israel, Brazil, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 64. Carbohydrate Intravenous Solutions - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, Brazil, South Africa and Other Countries
3.11.1.5 (I) Israeli Carbohydrate Intravenous Solutions Market
3.11.1.5 (II) Brazilian Carbohydrate Intravenous Solutions Market
3.11.1.5 (III) South African Carbohydrate Intravenous Solutions Market
3.11.2 Salt and Electrolyte
3.11.2.1 Global Salt and Electrolyte Intravenous Solutions Market
Exhibit 65. Salt and Electrolytes Intravenous Solutions - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 66. Salt and Electrolytes Intravenous Solutions - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe ,Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.2.2 North America Salt and Electrolyte Intravenous Solutions Market
Exhibit 67. Salt and Electrolyte Intravenous Solutions - North American Market Estimations & Predictions (2005 - 2020) by Country for US and Canada in US$ Billion (Graphical Representation Included)
Exhibit 68. Salt and Electrolyte Intravenous Solutions - North American Market Shares (2010, 2015 & 2020) by Country for US and Canada (Graphical Representation Included)
3.11.2.2 (I) US Salt and Electrolyte Intravenous Solutions Market
3.11.2.2 (II) Canadian Salt and Electrolyte Intravenous Solutions Market
3.11.2.3 European Salt and Electrolyte Intravenous Solutions Market
Exhibit 69. Salt and Electrolyte Intravenous Solutions - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 70. Salt and Electrolyte Intravenous Solutions - European Market Shares (2010, 2015 & 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.11.2.3 (I) German Salt and Electrolyte Intravenous Solutions Market
3.11.2.3 (II) French Salt and Electrolyte Intravenous Solutions Market
3.11.2.3 (III) UK Salt and Electrolyte Intravenous Solutions Market
3.11.2.3 (IV) Swiss Salt and Electrolyte Intravenous Solutions Market
3.11.2.3 (V) Russian Salt and Electrolyte Intravenous Solutions Market
3.11.2.4 Asia-Pacific Salt and Electrolyte Intravenous Solutions Market
Exhibit 71. Salt and Electrolyte Intravenous Solutions - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 72. Salt and Electrolyte Intravenous Solutions - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
3.11.2.4 (I) Japanese Salt and Electrolyte Intravenous Solutions Market
3.11.2.4 (II) Chinese Salt and Electrolyte Intravenous Solutions Market
3.11.2.4 (III) Indian Salt and Electrolyte Intravenous Solutions Market
3.11.2.4 (IV) Australian Salt and Electrolyte Intravenous Solutions Market
3.11.2.4 (V) South Korean Salt and Electrolyte Intravenous Solutions Market
3.11.2.5 Rest of World Salt and Electrolyte Intravenous Solutions Market
Exhibit 73. Salt and Electrolyte Intravenous Solutions - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Israel, Brazil, South Africa and Other Countries in US$ Million (Graphical Representation Included).
Exhibit 74. Salt and Electrolyte Intravenous Solutions - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, Brazil, South Africa and Other Countries
3.11.2.5 (I) Israeli Salt and Electrolyte Intravenous Solutions Market
3.11.2.5 (II) Brazillian Salt and Electrolyte Intravenous Solutions Market
3.11.2.5 (III) South African Salt and Electrolyte Intravenous Solutions Market
3.11.3 Mineral and Vitamin
3.11.3.1 Global Mineral and Vitamin Intravenous Solutions Market
Exhibit 75. Mineral and Vitamin Intravenous Solutions - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 76. Mineral and Vitamin Intravenous Solutions - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.3.2 North America Mineral and Vitamin Intravenous Solutions Market
Exhibit 77. Mineral and Vitamin Intravenous Solutions - North American Market Estimations & Predictions (2005 - 2020) by Country for US and Canada in US$ Billion (Graphical Representation Included)
Exhibit 78. Mineral and Vitamin Intravenous Solutions - North American Market Shares (2010, 2015 & 2020) by Country for US and Canada (Graphical Representation Included)
3.11.3.2 (I) US Mineral and Vitamin Intravenous Solutions Market
3.11.3.2 (II) Canadian Mineral and Vitamin Intravenous Solutions Market
3.11.3.3 European Mineral and Vitamin Intravenous Solutions Market
Exhibit 79. Mineral and Vitamin Intravenous Solutions - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
Exhibit 80. Mineral and Vitamin Intravenous Solutions - European Market Shares (2010, 2015 & 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.11.3.3 (I) German Mineral and Vitamin Intravenous Solutions Market
3.11.3.3 (II) French Mineral and Vitamin Intravenous Solutions Market
3.11.3.3 (III) UK Mineral and Vitamin Intravenous Solutions Market
3.11.3.3 (IV) Swiss Mineral and Vitamin Intravenous Solutions Market
3.11.3.3 (V) Russian Mineral and Vitamin Intravenous Solutions Market
3.11.3.4 Asia-Pacific Mineral and Vitamin Intravenous Solutions Market
Exhibit 81. Mineral and Vitamin Intravenous Solutions - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 82. Mineral and Vitamin Intravenous Solutions - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
3.11.3.4 (I) Japanese Mineral and Vitamin Intravenous Solutions Market
3.11.3.4 (II) Chinese Mineral and Vitamin Intravenous Solutions Market
3.11.3.4 (III) Indian Mineral and Vitamin Intravenous Solutions Market
3.11.3.4 (IV) Australian Mineral and Vitamin Intravenous Solutions Market
3.11.3.4 (V) South Korean Mineral and Vitamin Intravenous Solutions Market
3.11.3.5 Rest of World Mineral and Vitamin Intravenous Solutions Market
Exhibit 83. Mineral and Vitamin Intravenous Solutions - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Israel, Brazil, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 84. Mineral and Vitamin Intravenous Solutions - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, Brazil, South Africa and Other Countries
3.11.3.5 (I) Israeli Mineral and Vitamin Intravenous Solutions Market
3.11.3.5 (II) Brazillian Mineral and Vitamin Intravenous Solutions Market
3.11.3.5 (III) South African Mineral and Vitamin Intravenous Solutions Market
3.11.4 Amino-Acid
3.11.4.1 Global Amino-Acid Intravenous Solutions Market
Exhibit 85. Amino-Acid Intravenous Solutions - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 86. Amino-Acid Intravenous Solutions - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.11.4.2 North America Amino-Acid Intravenous Solutions Market
Exhibit 87. Amino-Acid Intravenous Solutions - North American Market Estimations & Predictions (2005 - 2020) by Country for US and Canada in US$ Billion (Graphical Representation Included)
Exhibit 88. Amino-Acid Intravenous Solutions - North American Market Shares (2010, 2015 & 2020) by Country for US and Canada (Graphical Representation Included)
3.11.4.2 (I) US Amino-Acid Intravenous Solutions Market
3.11.4.2 (II) Canadian Amino-Acid Intravenous Solutions Market
3.11.4.3 European Amino-Acid Intravenous Solutions Market
Exhibit 89. Amino-Acid Intravenous Solutions - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 90. Amino-Acid Intravenous Solutions - European Market Shares (2010, 2015 & 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.11.4.3 (I) German Amino-Acid Intravenous Solutions Market
3.11.4.3 (II) French Amino-Acid Intravenous Solutions Market
3.11.4.3 (III) UK Amino-Acid Intravenous Solutions Market
3.11.4.3 (IV) Swiss Amino-Acid Intravenous Solutions Market
3.11.4.3 (V) Russian Amino-Acid Intravenous Solutions Market
3.11.4.4 Asia-Pacific Amino-Acid Intravenous Solutions Market
Exhibit 91. Amino-Acid Intravenous Solutions - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 92. Amino-Acid Intravenous Solutions - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
3.11.4.4 (I) Japanese Amino-Acid Intravenous Solutions Market
3.11.4.4 (II) Chinese Amino-Acid Intravenous Solutions Market
3.11.4.4 (III) Indian Amino-Acid Intravenous Solutions Market
3.11.4.4 (IV) Australian Amino-Acid Intravenous Solutions Market
3.11.4.4 (V) South Korean Amino-Acid Intravenous Solutions Market
3.11.4.5 Rest of World Amino-Acid Intravenous Solutions Market
Exhibit 93. Amino-Acid Intravenous Solutions - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Israel, Brazil, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 94. Amino-Acid Intravenous Solutions - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, Brazil, South Africa and Other Countries
3.11.4.5 (I) Israeli Amino-Acid Intravenous Solutions Market
3.11.4.5 (II) Brazilian Amino-Acid Intravenous Solutions Market
3.11.4.5 (III) South African Amino-Acid Intravenous Solutions Market
3.11.5 Other Nutrients
3.11.5.1 Global Other Nutrient Intravenous Solutions Market
Exhibit 95. Other Nutrient Intravenous Solutions - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 96. Other Nutrient Intravenous Solutions - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
3.11.5.2 North America Other Nutrient Intravenous Solutions Market
Exhibit 97. Other Nutrient Intravenous Solutions - North American Market Estimations & Predictions (2005 - 2020) by Country for US and Canada in US$ Billion (Graphical Representation Included)
Exhibit 98. Other Nutrient Intravenous Solutions - North American Market Shares (2010, 2015 & 2020) by Country for US and Canada (Graphical Representation Included)
3.11.5.3 European Other Nutrient Intravenous Solutions Market
Exhibit 99. Other Nutrient Intravenous Solutions - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 100. Other Nutrient Intravenous Solutions - European Market Shares (2010, 2015 & 2020) by Country for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
3.11.5.4 Asia-Pacific Other Nutrient Intravenous Solutions Market
Exhibit 101. Other Nutrient Intravenous Solutions - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 102. Other Nutrient Intravenous Solutions - Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Japan, China, India, Australia, South Korea and Rest of Asia-Pacific
3.11.5.5 Rest of World Other Nutrient Intravenous Solutions Market
Exhibit 103. Other Nutrient Intravenous Solutions - Rest of World Market Estimations & Predictions (2005 - 2020) by Country for Israel, Brazil, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 104. Other Nutrient Intravenous Solutions - Rest of World Market Shares (2010, 2015 & 2020) by Country for Israel, Brazil, South Africa and Other Countries
3.12 Intravenous Solutions – Market Outlook

4. PRODUCT TECHNOLOGY/RESEARCH
4.1 Introduction
Intravenous Solutions
Composition
Exhibit 105. Daily Electrolyte Requirement
Exhibit 106. Electrolyte Contents for Common Fluids (mmol/litre)
Application
Exhibit 107. Intravenous Fluid Requirements in Different Clinical Situations 193
Types of Intravenous Solutions
Large Volume Parenterals and Small Volume Parenteral
Exhibit 108. Intravenous Fluid Comparison
Intravenous versus Oral Mode of Administration
Risks
Precautions
Fat Emulsions
Dextrose
Plasma Expanders
Cyclical Parenteral Nutrition
Advantages of Cyclical Parenteral Nutrition
Exhibit 109. Global Consumption of Intravenous Solutions
4.2 Segmentation of Intravenous Solutions
Partial Parenteral Nutrition
Total Parenteral Nutrition
Complications
Complications due to Catheter Insertion
Metabolic Complications
4.3 Segmentation by Nutrients
Carbohydrates
Carbohydrates: Source of Nutrition.
Introduction
Disadvantages of Over-feeding with the Carbon Source
Endogenous Glucose Production and Oxidation
Guidelines
Glucose/Fat Ratio
Salt and Electrolytes
Salt (Sodium chloride) and/ or Other Electrolytes
Saline
Concentrations
Minerals and Vitamins
Amino-Acids
Amino Acids and/or Protein Hydrolysates
Dosage of Amino-Acid Solutions for Intravenous Use
Other
Fat (lipid) Emulsions
Plasma Extenders
Exhibit 110. List of Agents Administered as IV Solutions or Additives
Packaging and Identification Labeling of API’s and Intermediates.
General
Packaging Materials
Label Issuance and Control
Packaging and Labeling Operations
Storage and Distribution
Warehousing Procedures
Distribution Procedures
Specific Guidance for API’s manufactured by Cell Culture/Fermentation
General
Cell Culture/Fermentation
Harvesting, Isolation and Purification
Viral Removal/Inactivation Steps
Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices
Safety Assessment Approach Used
Conclusions of the Safety Assessment
I V Infusion of Crystalloid Fluids and Drugs
Total Parenteral Nutrition (TPN)
Parenteral nutrition
Government of India –Policy and Regulations on Drugs
Drug Regulation and Control
Maharashtra FDA: Latest
Procedure for Drug Application in India
Import and Manufacturing Licenses and Approvals
Labeling Requirements
Drug Price Regulation
History of Drug Price Regulation
Trends in Drug Price Control – India
Regulations on Patent Protection
Finale
A Summary of the Chinese Pharmaceutical Market
Consolidating the System – The State Drug Administration
Pharmaceutical Regulations
Pricing and Reimbursement
Pharmaceutical Classification
Registration
Clinical Investigation
Legal Reform: Intellectual Property Rights
Conclusion
Application of Knowledge and Skills Framework and its Review Procedure
Introduction
Decision to Form NHS KSF
Purpose of Skills Framework
Mode of Function
Overview
Distribution of Pharmaceutical Products
4.4 Intravenous Solutions – Research Briefs

5. CORPORATE DIRECTORY

6. PATENTS INFORMATION

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 227898, price: INR 266304, RI Technologies

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online